Neuroprotection of edaravone on hypoxic-ischemic brain injury in neonatal rats

This publication has 54 references indexed in Scilit:

• Mechanisms of Hypoxic Neurodegeneration in the Developing Brain
  The Neuroscientist, 2002
• Phase I Clinical Study of MCI-186(Edaravone, 3-methyl-1-phenyl-2-pyrazolin-5-one) in Healthy Volunteers: Safety and Pharmacokinetics of Single and Multiple Administrations.
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1998
• The Immunosuppressant Drug FK506 Ameliorates Secondary Mitochondrial Dysfunction Following Transient Focal Cerebral Ischemia in the Rat
  Neurobiology of Disease, 1997
• Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
  Published by Elsevier ,1996
• Secondary bioenergetic failure after transient focal ischaemia is due to mitochondrial injury
  Acta Physiologica Scandinavica, 1996
• CPP32/Apopain Is a Key Interleukin 1β Converting Enzyme-like Protease Involved in Fas-mediated Apoptosis
  Journal of Biological Chemistry, 1996
• Lipid peroxidation as a measure of oxygen free radical damage in the very low birthweight infant.
  Archives of Disease in Childhood: Fetal & Neonatal, 1994
• Basic mechanisms of traumatic brain damage
  Annals of Emergency Medicine, 1993
• Nature, time-course, and extent of cerebral edema in perinatal hypoxic-ischemic brain damage
  Pediatric Neurology, 1993
• Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger.
  Stroke, 1988